Targeted Therapies Are Impacting the Treatment of NETs

Nicole Ross, MSN, CRNP, AOCNP, nurse practitioner for the department of hematology/oncology​ at Fox Chase Cancer Center, discusses how targeted therapies are impacting the treatment of NETs.

In a Pharmacy Times® interview, Nicole Ross, MSN, CRNP, AOCNP, nurse practitioner for the department of hematology/oncology​ at Fox Chase Cancer Center, about her presentation on neuroendocrine tumor (NETs) management in large cancer centers at the NANETS 2021 Conference.

She discussed how targeted therapies are impacting the treatment of NETs.

Related Videos
Credit: thodonal - stock.adobe.com
Credit: Lars Neumann - stock.adobe.com
Image Credit: Adobe Stock - peterschreiber.media
Conference attendees watching a speaker | Image credit: kasto - stock.adobe.com
Biosimilars | Image credit: lexiconimages - stock.adobe.com
Medical care team | Image credit: Iryna - stock.adobe.com
Pharmacist helping patient | Image credit: Zamrznuti tonovi - stock.adobe.com
Pharmacist in home infusion environment | Image credit: Satjawat - stock.adobe.com
Related Content
© 2023 MJH Life Sciences

All rights reserved.